Analysis of Motor Performance in Children with Duchene's Muscular Dystrophy
- Conditions
- Duchene's Muscular Dystrophy
- Registration Number
- NCT06750042
- Lead Sponsor
- Cairo University
- Brief Summary
25 boys, ages ranging from 6 to 16 years, diagnosed with Duchene's muscular Dystrophy (DMD) will participated in the study. They will be selected from the Pediatric Rehabilitation Center of Deraya University's outpatient clinic in El-Minia district, Minia-Egypt. The outcome will be assessed motor performance will be assed by Bruininks-Oseretsky Test of Motor Proficiency Second Edition (BOT™-2) : balance, running speed and agility, bilateral coordination and strength and by Blue Cherry; Geratherm Respiratory. It is used to measure vital capacity (VC), forced expired volume in one second (FEV1), FEV1/FVC, FEV1/VC, and peak expiratory flow (PEF) to provide objective information for monitoring lung health.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 25
- the diagnosis is Duchene's muscular Dystrophy only not other types,
- ambulated with or without assistance,
- oriented and endurance enough to understand orders to perform ventilation on the Blue Cherry; Geratherm Respiratory device.
- any cognitive or neurological condition (other than Duchene's muscular Dystrophy),
- history of previous surgical operations that can affect pulmonary functions, and structural scoliosis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method motor performance measured for one time motor performance will be assessed by Bruininks-Oseretsky Test of Motor Proficiency Second Edition (BOT™-2)
respiratory function measured for only one time respiratory function by Blue Cherry; Geratherm Respiratory. It is used to measure respiratory function to provide objective information for monitoring lung health.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.